Recent

% | $
Quotes you view appear here for quick access.

Northwest Biotherapeutics, Inc. Message Board

  • patriot1045 patriot1045 Feb 21, 2013 9:39 AM Flag

    Northwest Bio CEO Linda Powers on Fox Business News on Saturday, February 23rd at 2:30PM EST.

    Northwest Bio CEO Linda Powers on Fox Business News on Saturday, February 23rd at 2:30PM EST.

    ORLANDO, Fla., Feb. 20, 2013 (GLOBE NEWSWIRE) -- RedChip Companies, Inc. ("RedChip"), an international small-cap research, investor relations, and media company, today announced that "The RedChip Money Report"™ television program will feature three emerging growth companies nationally on Fox Business News, Saturday, February 23, 2013 at 2:30 p.m. Eastern.Fox Business News is a premium business network reaching more than 65 million homes nationwide. Among all cable networks, Fox Business News' viewership ranks second only to Bloomberg in affluence.

    This week's show features interviews with Seth Grae, CEO of Lightbridge Corp. (Nasdaq:LTBR), a U.S. nuclear energy company; James Czirr, Executive Chairman of Galectin Therapeutics, Inc. (Nasdaq:GALT), a biotechnology company; and Linda Powers, CEO of Northwest Biotherapeutics, Inc. (Nasdaq:NWBO), a cell therapy company.

    "The RedChip Money Report"™ delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. The show is hosted by Dave Gentry, a leading authority on small-cap stocks and president of RedChip, an international small-cap research firm and an Inc. 5000 company. Mr. Gentry has made multiple guest appearances on both CNBC and Fox Business News and has been a consultant to hundreds of public companies.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This is an excellent way to get public notice of NWBO. I have some GNBT as well and in Dec of 2011 they went on Bloomberg TV and the results we very good it went up over 200% in one week. We wiil see on Monday.. GLTA

      Sentiment: Strong Buy

      • 2 Replies to bobesaathoff
      • They need to be presenting at more biotech conferences. I think that's the plan too.

        Due to a variety of reasons, NWBO was very low-key through all of last year. I think December provided an inflection point and a departure from that mode. The fact that we had Dr. Bosch and Linda present at two conferencs in quick succesion is testimony to that fact. There is also a renewd confidence one senses in the way NWBO is putting it's case forward now. We should see more of them, and greater investor engagement, in the coming months.

        Sentiment: Strong Buy

      • Very informative..not pumped..sounds like we have huge winner and they are confident!

 
NWBO
7.34-0.12(-1.61%)1:05 PMEDT